Fenofibrate, probucol, and other lipid-lowering treatments in heart transplant recipients.
de Lorgeril
M
M
Boissonnat
P
P
Salen
P
P
Monjaud
I
I
Dureau
G
G
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D002792:Cholestyramine Resin / Q000627:therapeutic use; D016572:Cyclosporine / Q000493:pharmacokinetics / Q000627:therapeutic use; D004347:Drug Interactions; D011345:Fenofibrate / Q000627:therapeutic use*; D015248:Gemfibrozil / Q000627:therapeutic use; D016027:Heart Transplantation; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000493:pharmacokinetics / Q000627:therapeutic use; D008148:Lovastatin / Q000031:analogs & derivatives / Q000627:therapeutic use; D011341:Probucol / Q000627:therapeutic use*; D019821:Simvastatin
D000924:Anticholesteremic Agents; D000960:Hypolipidemic Agents; D007166:Immunosuppressive Agents; D002792:Cholestyramine Resin; D016572:Cyclosporine; D008148:Lovastatin; D019821:Simvastatin; D011341:Probucol; D015248:Gemfibrozil; D011345:Fenofibrate